Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extension Study of the PUMCH-E101 Clinical Trial: An Open-label, Single-center, Single-dose Study Evaluating the Safety, Tolerability, and Efficacy of Intravitreal Injection of PUMCH-E101 in Subjects With RDH12 Retinopathy in the Contralateral Eye

NCT07878572 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT07878572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07878572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extension Study of the PUMCH-E101 Clinical Trial: An Open-label, Single-center, Single-dose Study Evaluating the Safety, Tolerability, and Efficacy of Intravitreal Injection of PUMCH-E101 in Subjects With RDH12 Retinopathy in the Contralateral Eye
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
December 15, 2025
Completion date
December 15, 2030
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inherited retinal diseases